biopolymers, yeast strains, development of novel strategies for antibody testing

myBIOS GmbH

The company focuses on the production of protein-based (biological) molecules with unique physical and biochemical properties. With its recombinant antigens, myBIOS GmbH develops novel strategies for antibody testing and the basis for vaccine tests. In the future, another focus will be the production and research of alternatives to antibiotics.